表紙
市場調查報告書
商品編碼
1056568

帕金森氏症的腦深部刺激療法的全球市場:各產品,各終端用戶,各地區-預測(∼2027年),COVID-19的累積性的影響

Deep Brain Stimulation in Parkinson's Disease Market Research Report by Product, by End-user, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 207 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球帕金森氏症的腦深部刺激療法的市場規模在2020年估算為7億1,267萬美元。2021年達到8億1,587萬美元,2027年為18億8,568萬美元,在預測期間內的年複合成長率將為14.91%。

本報告提供全球帕金森氏症的腦深部刺激療法市場相關調查分析,提供市場概要,市場洞察,市場分析,競爭情形等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 假設
  • 利害關係者

第2章 調查手法

  • 簡介
  • 定義:調查目的
  • 決策:調查設計
  • 準備:調查設備
  • 收集:資料來源
  • 分析:資料的解釋
  • 制定:資料檢驗
  • 公開:調查報告
  • 重複:報告的更新

第3章 摘要整理

第4章 市場概要

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19累積的影響

第6章 帕金森氏症的腦深部刺激療法市場:各產品

  • 簡介
  • 雙通道
  • 單通道

第7章 帕金森氏症的腦深部刺激療法市場:各終端用戶

  • 簡介
  • 門診病人手術中心
  • 醫院
  • 神經內科診所
  • 研究中心

第8章 南北美洲的帕金森氏症的腦深部刺激療法市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區的帕金森氏症的腦深部刺激療法市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國

第10章 歐洲·中東·非洲的帕金森氏症的腦深部刺激療法市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析:各主要企業
  • 競爭模式
    • 合併和收購
    • 協定,合作,及的夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Allergan Plc
  • Beijing PINS Medical Co. Ltd
  • Boston Scientific Corporation
  • Cyberonics, Inc
  • Fisher Wallace
  • Functional Neuromodulation Ltd
  • LIVANOVA PLC
  • Medtronic PLC
  • MicroTransponder Inc
  • Neuronetics Inc.
  • NeuroPace Inc.
  • NeuroSigma, Inc.
  • Nevro Corporation
  • Nexstim Oy
  • Renishaw PLC
  • ReShape Lifesciences, Inc
  • Synapse Biomedical Inc
  • Zynex, Inc

第13章 附錄

  • 討論指南
  • 許可證和價格
目錄
Product Code: MRR-A339DAEFA8A2

The Global Deep Brain Stimulation in Parkinson's Disease Market size was estimated at USD 712.67 million in 2020 and expected to reach USD 815.87 million in 2021, at a CAGR 14.91% to reach USD 1,885.68 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Deep Brain Stimulation in Parkinson's Disease to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Dual Channel and Single Channel.

Based on End-user, the market was studied across Ambulatory Surgical Centers, Hospitals, Neurology Clinics, and Research Centers.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Deep Brain Stimulation in Parkinson's Disease Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Deep Brain Stimulation in Parkinson's Disease Market, including Abbott Laboratories, Aleva Neurotherapeutics SA, Allergan Plc, Beijing PINS Medical Co. Ltd, Boston Scientific Corporation, Cyberonics, Inc, Fisher Wallace, Functional Neuromodulation Ltd, LIVANOVA PLC, Medtronic PLC, MicroTransponder Inc, Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nevro Corporation, Nexstim Oy, Renishaw PLC, ReShape Lifesciences, Inc, Synapse Biomedical Inc, and Zynex, Inc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Deep Brain Stimulation in Parkinson's Disease Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Deep Brain Stimulation in Parkinson's Disease Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Deep Brain Stimulation in Parkinson's Disease Market?
  • 4. What is the competitive strategic window for opportunities in the Global Deep Brain Stimulation in Parkinson's Disease Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Deep Brain Stimulation in Parkinson's Disease Market?
  • 6. What is the market share of the leading vendors in the Global Deep Brain Stimulation in Parkinson's Disease Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Deep Brain Stimulation in Parkinson's Disease Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of neurological diseases
      • 5.1.1.2. Rapidly aging population, leading to risk and high prevalence of neurological disorders
      • 5.1.1.3. Rising popularity of minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Complex regulatory framework
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing technological advancement in devices
      • 5.1.3.2. Surge in neurological R&D
    • 5.1.4. Challenges
      • 5.1.4.1. Risks of deep brain stimulation surgery
  • 5.2. Cumulative Impact of COVID-19

6. Deep Brain Stimulation in Parkinson's Disease Market, by Product

  • 6.1. Introduction
  • 6.2. Dual Channel
  • 6.3. Single Channel

7. Deep Brain Stimulation in Parkinson's Disease Market, by End-user

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Neurology Clinics
  • 7.5. Research Centers

8. Americas Deep Brain Stimulation in Parkinson's Disease Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Aleva Neurotherapeutics SA
  • 12.3. Allergan Plc
  • 12.4. Beijing PINS Medical Co. Ltd
  • 12.5. Boston Scientific Corporation
  • 12.6. Cyberonics, Inc
  • 12.7. Fisher Wallace
  • 12.8. Functional Neuromodulation Ltd
  • 12.9. LIVANOVA PLC
  • 12.10. Medtronic PLC
  • 12.11. MicroTransponder Inc
  • 12.12. Neuronetics Inc.
  • 12.13. NeuroPace Inc.
  • 12.14. NeuroSigma, Inc.
  • 12.15. Nevro Corporation
  • 12.16. Nexstim Oy
  • 12.17. Renishaw PLC
  • 12.18. ReShape Lifesciences, Inc
  • 12.19. Synapse Biomedical Inc
  • 12.20. Zynex, Inc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
  • FIGURE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2027
  • FIGURE 6. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, 2018-2027 (USD MILLION)
  • FIGURE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, 2018-2027 (USD MILLION)
  • FIGURE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 10. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
  • FIGURE 11. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2027
  • FIGURE 13. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
  • FIGURE 14. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 15. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
  • FIGURE 16. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, 2018-2027 (USD MILLION)
  • FIGURE 18. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 19. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, 2018-2027 (USD MILLION)
  • FIGURE 20. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 21. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 22. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 23. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 24. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 25. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 26. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 27. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 28. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 29. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 30. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 31. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 32. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 33. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 34. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 35. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 36. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 37. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 38. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 39. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 40. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 41. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 42. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 43. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 44. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 45. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 46. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 47. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 48. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 49. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 50. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 51. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 52. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11. AMERICAS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 12. ARGENTINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 13. BRAZIL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 14. CANADA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 15. MEXICO DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 16. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 17. ASIA-PACIFIC DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 18. AUSTRALIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 19. CHINA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 20. INDIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 21. INDONESIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 22. JAPAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 23. MALAYSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 24. PHILIPPINES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 25. SINGAPORE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 26. SOUTH KOREA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 27. TAIWAN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 28. THAILAND DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 29. EUROPE, MIDDLE EAST & AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 30. FRANCE DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 31. GERMANY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 32. ITALY DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 33. NETHERLANDS DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 34. QATAR DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 35. RUSSIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 36. SAUDI ARABIA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 37. SOUTH AFRICA DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 38. SPAIN DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 39. UNITED ARAB EMIRATES DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 40. UNITED KINGDOM DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 41. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: SCORES
  • TABLE 42. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: BUSINESS STRATEGY
  • TABLE 43. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: PRODUCT SATISFACTION
  • TABLE 44. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: RANKING
  • TABLE 45. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 46. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: MERGER & ACQUISITION
  • TABLE 47. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 48. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 49. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: INVESTMENT & FUNDING
  • TABLE 50. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 51. GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET: LICENSE & PRICING